Mitsubishi UFJ Asset Management Co., Ltd. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management Co., Ltd. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$276,144
+11.2%
13,477
+7.9%
0.00%0.0%
Q2 2023$248,296
-11.6%
12,496
-23.8%
0.00%0.0%
Q1 2023$280,795
-5.0%
16,392
+6.3%
0.00%0.0%
Q4 2022$295,428
-26.5%
15,419
-38.8%
0.00%0.0%
Q3 2022$402,000
+17.9%
25,205
+1.8%
0.00%
-50.0%
Q2 2022$341,000
+86.3%
24,761
+114.2%
0.00%
+100.0%
Q1 2022$183,000
-27.4%
11,561
+8.8%
0.00%0.0%
Q4 2021$252,000
+11.0%
10,629
+40.1%
0.00%0.0%
Q3 2021$227,000
-30.6%
7,586
+2.9%
0.00%
-50.0%
Q2 2021$327,000
-30.9%
7,375
-30.8%
0.00%
-33.3%
Q1 2021$473,000
+21.0%
10,662
+49.4%
0.00%0.0%
Q4 2020$391,000
+68.5%
7,137
-29.6%
0.00%
+50.0%
Q3 2020$232,000
+10.5%
10,135
+1.1%
0.00%0.0%
Q2 2020$210,000
+30.4%
10,020
-13.3%
0.00%0.0%
Q1 2020$161,000
-21.1%
11,562
+26.2%
0.00%
-33.3%
Q4 2019$204,000
+108.2%
9,165
+8.4%
0.00%
+50.0%
Q3 2019$98,000
-4.9%
8,452
+23.1%
0.00%0.0%
Q2 2019$103,000
-46.6%
6,867
-37.6%
0.00%
-50.0%
Q1 2019$193,000
+26.1%
11,013
+8.0%
0.00%0.0%
Q4 2018$153,000
-6.1%
10,199
+54.5%
0.00%
+33.3%
Q3 2018$163,0006,6010.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders